HUTCHMED (China) (HCM) Stock
HUTCHMED (China) (HCM) closed at $14.90 on Nov 13, 2026; its Tenet Score is 49 of 100 against 409 Healthcare peers.
15 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $14.90
- Nov 13, 2026
- Market cap
- $2.6Bunverified basis
- share basis not confirmed
- P/E
- 5.7×
- price ÷ earnings
- 52-week range
- 9.77 – 16.33
- low → high
- Tenet Score
- 49/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
HUTCHMED (China) Limited scores 49/100. Mixed. Strongest on financial health, quality is the soft spot, trading at 6× earnings versus 409 Healthcare peers. Insufficient inputs: Tenet 49 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Value omitted — no data yet.
Price
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ✕ Quality Compounder
- ~ Drawdown Context
- ✓ Reversal Evidence
- ✓ Not-a-Value-Trap Gate
- ✕ Quality Floor
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company dev…
Common questions
What sector and industry is HUTCHMED (China) in?
HUTCHMED (China) is in the Healthcare sector and the Drugs industry.
What is HUTCHMED (China)'s Tenet Score?
HUTCHMED (China)'s Tenet Score is 49 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




